STEMI Watch - Module 3 : In-hospital Treatment

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: February 2016

Valid through: February 2019

Target Audience

This CME/CNE activity is intended for cardiologists, coronary care nurses and staff, emergency medicine physicians and nurses, emergency medical service providers, ECG staff, percutaneous coronary intervention center staff, freestanding emergency department staff.

Objectives

At the conclusion of this activity, participants should be able to:

  • Discuss current scientific research and data regarding the diagnosis of ST segment elevation myocardial infarction (STEMI).
  • Discuss the pathogenesis and treatment of STEMI;
  • Cite new information regarding new drugs for STEMI and new uses for traditional drugs;
  • Identify ancillary issues of importance for healthcare providers who treat STEMI patients.
  • Discuss advances in STEMI treatment.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credit(s)

Nurses

  • 2.0 Nursing contact hours

All other healthcare professionals completing this course will be issued a statement of participation.

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AHC Media is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

This activity has been approved for 2.0 nursing contact hours using a 60-minute contact hour.

Faculty Listing

Authors

Jeffrey Zimmet, MD, PhD
Associate Professor of Medicine, University of California, San Francisco, Director, Cardiac Catheterization Laboratory, San Francisco VA Medical Center

Michael H. Crawford, MD
Professor of Medicine, Chief of Clinical Cardiology University of California, San Francisco

Martin S. Lipsky, MD
Adjunct Professor, Institute on Aging, School of Community Health, Portland State University; Dean Emeritus, University of Illinois College of Medicine, Rockford

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine, UCLA School of Medicine

Brenda Mooney
Special Contributor to AHC Media

Jeff Unger, MD, ABFM, FACE
Director, Unger Primary Care Concierge Medical Group, Rancho Cucamonga, CA

Editor

Editor in Chief: Michael H. Crawford, MD
Professor of Medicine, Chief of Clinical Cardiology University of California, San Francisco

Peer Reviewer

Susan Zhao, MD
Director, Adult Echocardiography Laboratory; Associate Chief, Division of Cardiology, Department of Medicine, Santa Clara Valley Medical Center, Santa Clara, CA

Nurse Planner

Aurelia Macabasco-O’Connell, PhD, ACNP-BC, RN, PHN, FAHA
Associate Professor, Azusa Pacific University School of Nursing, Azusa, CA

AHC Media executive editor: Leslie G. Coplin
Associate managing editor: Jonathan Springston

Financial Disclosure

In order to reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, Dr. Lipsky is a retained consultant for Health Solutions & Strategies. Dr. Unger does research for Novo Nordisk, Lilly, Sanofi-Aventis, Janssen, GSK, Itarcica, Dance Pharma, Proteus Pharma, and Abbott Diabetes; is a consultant for Novo Nordisk, Janssen, Itarcica, Dance Pharma, Proteus Pharma, and Abbott Diabetes; is on the speaker’s bureau for Novo Nordisk, Janssen, and Valeritas; and is a stockholder for Novo Nordisk. Dr. Crawford, Dr. Zhao, Dr. Macabasco-O’Connell, Dr. Karpman, Dr. Zimmet, Ms. Mooney, Ms. Coplin, and Mr. Springston report no financial relationships relevant to this field of study.

 

Copyright 2016, AHC Media. All rights reserved.